GE HealthCare Technologies Inc. which can be found using ticker (GEHC) now have 12 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $97.00 and $66.00 calculating the average target price we see $83.88. Now with the previous closing price of $74.11 this indicates there is a potential upside of 13.2%. There is a 50 day moving average of $73.22 and the 200 moving average now moves to $74.22. The total market capitalization for the company now stands at 33.98B. The stock price is currently at: $74.64 USD
The potential market cap would be $38,458,871,064 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 22.15, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
